INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | ₹0.70 Cr | ₹10 Cr | ₹0.50 Cr | ₹0.50 Cr |
What is the latest Contingent Liabilities ratio of INDEGENE ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | ₹0.70 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹0.50 Cr |
| Mar2021 | ₹0.50 Cr |
How is Contingent Liabilities of INDEGENE Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹0.70 Cr | -93.07 | |
| Mar2023 | ₹10 Cr | 1,924.05 | |
| Mar2022 | ₹0.50 Cr | 0.00 | |
| Mar2021 | ₹0.50 Cr | - | |
Compare Contingent Liabilities of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹11,778.8 Cr | -0.3% | 10.3% | -9.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,243.0 Cr | -1.4% | -7.2% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,179.0 Cr | 5.7% | 0.3% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,670.0 Cr | 1.5% | -6.5% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,932.0 Cr | 0.7% | -7.4% | 9.9% | Stock Analytics | |
| CIPLA | ₹99,417.9 Cr | 0.5% | -7.1% | -14.4% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | -0.3% |
10.3% |
-9.9% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses